Vertex Q1 2026 Earnings Update

Written by

in

Vertex delivered a solid first quarter, but the more important message was not simply the 8% revenue growth. It was that the company is becoming less dependent on cystic fibrosis alone, while still using CF as the financial engine to fund a much broader pipeline. Total revenue increased to $2.99 billion, up 8% year over […]

You are unauthorized to view this page.

  • Rummu provides data, analysis, and tools for research purposes only. The information presented does not constitute financial advice, a recommendation, or an offer to buy or sell any securities. It does not take into account individual objectives, financial situations, or needs. You are solely responsible for your own investment decisions.